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Autoimmune hemolytic anemia due to drugs is an immunologic
condition characterized by the destruction of red blood cells induced
by the antibodies that bind to the surface antigens of red blood cell
membranes.1 Hydrochlorothiazides are commonly used diuretic or
antihypertensive agents. While immune hemolytic anemia due to
hydrochlorothiazide is rare, severe hemolytic anemia cases have been
reported. In this study, we aimed to present a patient who had been
taking hydrochlorothiazide for the treatment of hypertension and was
thought to develop autoimmune hemolytic anemia due to the drug.Case report
Eighty-year-old male patient admitted to the emergency unit for
paleness, icterus of sclera, shortness of breath, weakness, fatigue, and
chest pain that started 20 days ago and increased gradually. According
to his medical history, he underwent aorto-coronary bypass surgery
15 years ago and had a stent implanted 3 years ago. ECG showed ST
depression in derivations V1–V6. Troponin showed a normal level of
0.01 μg/L. The patient was diagnosed with acute coronary syndrome
and taken to the coronary intensive care unit where anti-ischemic
therapy was started. His hemoglobin (Hb) and hematocrit (Hct) values
were 7.5 g/dL (normal range: 13.2–17.4 g/dL) and 21% (normal range:, Elazig Training and Research
ey. Tel.: +90 424 238 10 00;
.
diovascular Academy.
y. Production and hosting by Elsev39–51%), respectively. Of the erythrocyte indices,mean corpuscular vol-
ume (MCV) was 100 fL (normal range: 76–96 fL), mean corpuscular he-
moglobin (MCH) was 23.6 pg/cells (normal range: 27–33 pg/cells), and
mean corpuscular hemoglobin concentration (MCHC) was 27.1 g/dL
(normal range: 30–35.5 g/dL). Fragmented normochromic red blood
cells and anisocytosis were seen in the peripheral blood smear. Reticulo-
cyte rate was found as 3%. In addition, thrombocyte count was
211 × 103/μL (normal range: 150–450 × 103/μL). Biochemical parame-
ters were as follows: blood urea nitrogen 90 mg/dL (normal range: 10–
50 mg/dL), serum creatinine 1.1 mg/dL (normal range: 0.6–1.2 mg/dL),
and serum sodium 136 mmol/L (normal range: 135–145 mmol/L) and
potassium 4.8 mmol/L (normal range: 3.5–5.1 mmol/L). Of coagulation
tests, prothrombin time (PT) was 13 s (normal range: 11–14 s), the
reference range for international normalized ratio (INR) was 1.15
(normal range: 0.8–1.2), and activated partial thromboplastin time
(aPTT) was 27.6 s (normal range: 21–36 s).
One unit of red blood cell suspension was given. Hb and Htc levels
were increased to 9.6 g/dL and 24.6%, respectively; and then to 10.7 g/dl
and 26.8%, respectively, following the administration of a second suspen-
sion of red blood cells. Vitamin B12 level was normal, folic acid level was
low and ferritin level was high which were 242 pg/mL (normal range:
191–663 pg/mL), 4.5 ng/mL (normal range: 4.6–18.7 ng/mL) and
1080 ng/mL (normal range: 30–400 ng/mL), respectively. Control com-
plete blood count values at day 2 were 8.5 g/dL for Hb and 22.1% for
Hct. Consultation was requested from internal medicine department.
Occult blood test in the stool was negative. Endoscopy was per-
formed to exclude gastrointestinal bleeding. Thus, active gastrointes-
tinal hemorrhage was excluded. Abdominal ultrasound revealed no
intra-abdominal hematoma, mass, or hepatomegaly or splenomegaly.
Indirect Coombs test was negative, but direct Coombs was positive as
IgG+2. Lactate dehydrogenase (LDH)was increased to 741 U/L (normalier B.V. All rights reserved. This is an open access article under the CC BY-NC-ND license
Table 2
Mechanism of drugs that cause immune hemolytic anemia.
Mechanism Drug absorption
(Hapten)
Immune complex Auto-antibody
DAT Positive anti-IgG Positive anti-C3 Positive anti-IgG
Location of
hemolysis
Extravascular Intravascular Extravascular
Drug Penicillin Quinidine Alpha-methyldopa
Ampicillin Phanecetin Mefenamic acid
Methicillin Hydrochlorothiazide L-Dopa
Carbenicillin Rifampin Procainamide
Cephalothin Sulfonamide Ibuprofen
Cephalordin Isoniazid Diclofenac
Insulin Interferon Alpha
Tetracycline
Melphalan
Acetaminophen
Hydralazine
Probenecid
Chlorpromazine
Streptomycin
Fluorouracil
Sulindac
DAT: direct antiglobulin test.
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2 g/L). Yes, total bilirubin and direct bilirubin levels were high which
were 2.6 mg/dL (normal range: 0–1.2 mg/dL) and 1.1 mg/dL (normal
range: 0–0.3 mg/dL), respectively. Urine analysis revealed proteinuria,
and (+) bilirubin and (+++) hemoglobin. ANA serum dilution was
negative. It was understood from his medical records that hemoglobin
and Hct levels were 13.1 g/dL and 38.7%, respectively, 20 days ago.
When his medical history was reviewed, it was seen that he was started
on daily irbesartan 150 mg plus hydrochlorothiazide 12.5 mg for high
blood pressure. The patient was then transferred to internal medicine
clinic with the current ﬁndings for hemolytic anemia due to thiazide.
Then, hydrochlorothiazide was stopped. After that, trandolapril was
started for treatment of hypertension. The patient was put on follow-
up program with periodic complete blood count analysis. At the end of
the next following 2 weeks, a negative Coombs test result and a hemo-
globin value of 10.5 g/dL were obtained. During follow-up, the hemoglo-
bin values were 13.1 g/dL and 13.3 g/dL, 1 month later and 3 months
later, respectively.
Discussion
Drug-associated hemolytic anemia is seen approximately in one out
of a million individual. It may be lethal, possibly with no diagnosis
established.2 It was found out in 2007 that up to 125 different drugs
may cause hemolysis.3 Forty years ago, back when methyldopa and an-
tibiotics like high doses of intravenous penicillin had been used com-
monly, most of the reported cases of hemolytic anemia were due to
the use of these agents. Today, however, cases of hemolytic anemia
are rather associated with cephalosporins since methyldopa is almost
no more used and second- and third-generation cephalosporins are
the leading antibiotics.4,5
Hemolytic anemia associatedwith drugs occurs through one of three
basicmechanisms6–9: (i) drug absorptionmechanism,where antibodies
against the drug react with the adsorbed drug on the surface of red
blood cell membrane. The antibody–antigen complex that is formed
on the surface of red blood cell membrane is removed from the circula-
tion by reticulo-endothelial system, thus resulting in extravascular he-
molysis; (ii) immune complex mechanism, in which drug–antibody
complex binds to the red blood cell membrane activating the comple-
ment cascade; this process leads to acute intravascular hemolysis; and
(iii) auto-antibody type, in which antibodies against the drug bind to
red blood cellmembrane through cross reaction resulting in extravascu-
lar hemolysis (Table 2). (See Table 1.)
Anemia associated with hydrochlorothiazide is an example of im-
mune complex-type immune hemolytic anemias. Intravascular hemo-
lysis develops as a result of activation of complement system by the
binding of the drug to the red blood cell membrane and may be severe
and fatal. Anemia, fragmented red blood cells on peripheral smear,
hyperbilirubinemia, increased levels of LDH, reticulocytosis, positive
Coombs test, hemoglobinuria and ﬁndings related with organ failures
may be observed depending on the severity of hemolysis.5 In our
case, an immune event was considered since anemia, weakness andTable 1
Laboratory values of the patient.
Hb Hct RBCs Total bil. Direct bil. LDH
Day (g/dL) % 106/μL (mg/dL) (mg/dL) (U/L)
20 d ago 3.1 38 4.00 0.35 0.35 294
Day 1 7.5 21 2.07 1.54 0.70 322
Day 2 9.6 26.8 2.41
Day 3 10.7 26.8 2.69 255
Day 4 8.5 22.1 2.18 2.99 1.14 347
Day 5 9.5 24.2 2.40 2.46 741
3 m later 13.3 40.5 3.87 0.55 0.21 382
Hb: hemoglobin; Htc: hematocrit; RBCs: red blood cells; Bil: bilirubin; LDH: lactate
dehydrogenase; d: days; m: months.shortness of breath were gradually increased after hydrochlorothiazide
was startedwith the absence of an anemia 20 days ago, accompanied by
the fall in hemoglobin values following the administration of red blood
cell suspensions and a positive Coombs test. Presence of fragmented red
blood cells, hyperbilirubinemia, hemoglobinuria and decreased levels
of haptoglobin (b0.3, normal range over the age of 50: 0.47–2.1 g/L)
were among ﬁndings that demonstrated an intravascular hemolysis in
our case.
In practice, Coombs test is used to investigate and diagnose these
types of hemolysis. This test is a laboratory method used to identify
the presence of incomplete antibodies attached to the red blood cells
or circulating freely and is also known as antiglobulin test.10 Positive
direct Coombs test may indicate a hemolysis that develops through an
immune complex-type reaction. In our case, polyspeciﬁc direct Coombs
test IgG was positive and indirect Coombs test was negative.
In 1976, Vila et al.11 had observed, for the ﬁrst time, the episodes in a
67-year-old patient whom they treated with a combination of methyl-
dopa and hydrochlorothiazide for hypertension during 4 years and
associated the mild to moderate hemolytic anemia with the thiazide
fraction of the medication. In 1980, Garratty et al.12 observed a severe
immune hemolytic anemia and renal failure in a 24-year-old black pa-
tient who ingested 15–20 tablets of methyldopa plus hydrochlorothia-
zide to commit suicide. They associated the hemolytic anemia with
the antibodies associated with hydrochlorothiazide through immune
complex mechanism. In these two cases of intravascular hemolysis,
antibodies were developed against hydrochlorothiazide but not against
methyldopa. In 1986, Shirey et al.13 considered hemolytic anemia due to
a drug when direct antiglobulin tested positive in a 53-year-old black
female. They found similar antibodies against diuretics by character-
izing hydrochlorothiazide antibody in serologic studies and offered an
alternate diuretic therapy for patients.
Mortality is reported to be 40% when hemolytic anemia associated
with drugs is assessedwhere hemolytic anemia due to ceftriaxones is as-
sociated with higher mortality among them.5 Beck et al.14 observed a
case of hemolytic anemia in a 53-year-old blackmale patient 18months
after starting hydrochlorothiazide and methyldopa. It was the ﬁrst
case that ended upwith death after hemolytic anemia due to hydrochlo-
rothiazide. The patient had a positive direct and indirect Coombs test, a
low level of haptoglobin of 0.5 g/dL and a high LDH in whom cause of
death could not be established in autopsy butwas considered as fatal im-
mune hemolytic anemia associated with the use of hydrochlorothiazide.
Anemia may sometimes immediately be demonstrated by seri-
ous clinical ﬁndings while the diagnosis may be delayed as long as
113Ö. Seçen, I. Karaca / International Journal of the Cardiovascular Academy 2 (2016) 111–1131–2 weeks after the intake of the drug in cases without a serious hemo-
lysis, and anemia may be associated with other causes without any
established diagnosis.15 In our patient, amoderate anemia accompanied
by a mild increase in LDH levels and positive Coombs test were found
20 days after the intake of the drug since the hemolysis was not severe.
Cessation of the drug in mild cases and steroids plus supportive
care in more severe cases are recommended.16,17 In our patient, the
moderate anemia was recovered without any treatment after stopping
hydrochlorothiazide.
The diagnosis of hemolytic anemia associated with drugs was
established in our patient based on medical history and clinical signs
and symptoms. Presence of fragmented red blood cells and hemoglo-
binuria suggested an intravascular hemolysis.
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